These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25968877)

  • 41. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.
    Zhang M; Dong Y; Liu H; Wang Y; Zhao S; Xuan Q; Wang Y; Zhang Q
    Sci Rep; 2016 Nov; 6():37933. PubMed ID: 27892511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer.
    Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G
    Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
    Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
    Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
    Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
    PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic role of high Bmi-1 expression in Asian and Caucasian patients with solid tumors: a meta-analysis.
    Shao Y; Geng Y; Gu W; Ning Z; Jiang J; Pei H
    Biomed Pharmacother; 2014 Oct; 68(8):969-77. PubMed ID: 25458792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis.
    Hu H; Cai W; Zheng S; Ge W
    Cell Physiol Biochem; 2017; 44(4):1485-1496. PubMed ID: 29190626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
    Cheng H; Wang X; Li T; Chen L
    Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
    Wu JX; Zhao YY; Wu X; An HX
    PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma.
    Rodrigues MFSD; Xavier FCA; Andrade NP; Lopes C; Miguita Luiz L; Sedassari BT; Ibarra AMC; López RVM; Kliemann Schmerling C; Moyses RA; Tajara da Silva EE; Nunes FD
    Head Neck; 2018 Aug; 40(8):1759-1773. PubMed ID: 29607565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Prognostic and Clinicopathological Roles of Sirtuin-3 in Various Cancers.
    Yu FY; Xu Q; Wu DD; Lau AT; Xu YM
    PLoS One; 2016; 11(8):e0159801. PubMed ID: 27483432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.
    Gu X; Gao XS; Ma M; Qin S; Qi X; Li X; Sun S; Yu H; Wang W; Zhou D
    Oncotarget; 2016 Oct; 7(43):69666-69673. PubMed ID: 27626167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis.
    Luo G; Hu Y; Zhang Z; Wang P; Luo Z; Lin J; Cheng C; Yang Y
    Oncotarget; 2017 Jul; 8(30):50273-50283. PubMed ID: 28488584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
    Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
    Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trop2 is overexpressed in gastric cancer and predicts poor prognosis.
    Zhao W; Zhu H; Zhang S; Yong H; Wang W; Zhou Y; Wang B; Wen J; Qiu Z; Ding G; Feng Z; Zhu J
    Oncotarget; 2016 Feb; 7(5):6136-45. PubMed ID: 26716416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas.
    Ishikawa D; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Yamada S; Miyake H
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2032-7. PubMed ID: 24909638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
    Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
    Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
    Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological significance and prognostic role of microvessel density in gastric cancer: A meta-analysis.
    Hong WG; Ko YS; Pyo JS
    Pathol Res Pract; 2017 Dec; 213(12):1459-1463. PubMed ID: 29129495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.